Orient EuroPharma Co., Ltd.
4120.TWO
Price:
$44.85
Market Cap:
$3.89B
Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include cardiovascular, metabolism, neurology, obstetrics and gynecology, respiratory, andrology, immunology, antibiotic, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk and nutritional supplements under the Karihome, Babecare, and Ostricare brands; and healthcare supplements, such as thermal water for the treatment of oral and periodontal diseases under the Buccotherm name. In addition, the company offers essences, creams, lotions, eye creams, facial treatment toners, and skin repairing essences under the AGLab name; ski...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2007-12-31
Stock Exchange
TWO
Ticker
4120.TWO
PE Ratio
[-8.41]
ROE
[-5.85%]
Current Ratio
[1.39]
Dividend Yield
[2.23%]
Enterprise Value
[5.57B]
Dividend History
The ROE as of December 2025 (TTM) for Orient EuroPharma Co., Ltd. (4120.TWO) is -5.85%
According to Orient EuroPharma Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -5.85%. This represents a change of 294.89% compared to the average of -1.48% of the last 4 quarters.
Orient EuroPharma Co., Ltd. (4120.TWO) Historical ROE (quarterly & annually)
How has 4120.TWO ROE performed in the past?
The mean historical ROE of Orient EuroPharma Co., Ltd. over the last ten years is -0.29%. The current -5.85% ROE has changed 1.94% with respect to the historical average. Over the past ten years (40 quarters), 4120.TWO's ROE was at its highest in in the December 2023 quarter at 9.67%. The ROE was at its lowest in in the June 2023 quarter at -5.87%.
Average
-0.29%
Median
2.04%
Minimum
-10.61%
Maximum
6.21%
Orient EuroPharma Co., Ltd. (4120.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of Orient EuroPharma Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual ROE = 6.21%
Minimum Annual Increase = -359.75%
Minimum Annual ROE = -10.61%
| Year | ROE | Change |
|---|---|---|
| 2024 | -5.50% | -234.25% |
| 2023 | 4.10% | -138.60% |
| 2022 | -10.61% | -359.75% |
| 2021 | 4.09% | -34.23% |
| 2020 | 6.21% | Infinity% |
Orient EuroPharma Co., Ltd. (4120.TWO) Average ROE
How has 4120.TWO ROE performed in the past?
The current ROE of Orient EuroPharma Co., Ltd. (4120.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.00%
5-year avg
-0.34%
10-year avg
-0.29%
Orient EuroPharma Co., Ltd. (4120.TWO) ROE vs. Peers
How is 4120.TWO’s ROE compared to its peers?
Orient EuroPharma Co., Ltd.’s ROE is greater than Senhwa Biosciences, Inc. (-27.83%), greater than Energenesis Biomedical CO.,LTD. (-32.50%), greater than Formosa Pharmaceuticals, Inc. (-3.92%), greater than BRIM Biotechnology, Inc. (-11.90%), greater than AnnJi (-54.10%), greater than Medigen Biotechnology Corp. (-3.79%), less than Nang Kuang Pharmaceutical Co., Ltd. (11.34%), greater than Bionime Corporation (-6.07%), greater than TWi Biotechnology, Inc. (-69.83%), less than Maxigen Biotech Inc. (14.86%),
| Company | ROE | Market cap |
|---|---|---|
| -27.83% | $3.59B | |
| -32.50% | $3.81B | |
| -3.92% | $4.23B | |
| -11.90% | $3.70B | |
| -54.10% | $4.31B | |
| -3.79% | $4.28B | |
| 11.34% | $3.86B | |
| -6.07% | $3.93B | |
| -69.83% | $2.04B | |
| 14.86% | $3.94B |
Build a custom stock screener for Orient EuroPharma Co., Ltd. (4120.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orient EuroPharma Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Orient EuroPharma Co., Ltd. (4120.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Orient EuroPharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Orient EuroPharma Co., Ltd.'s ROE?
How is the ROE calculated for Orient EuroPharma Co., Ltd. (4120.TWO)?
What is the highest ROE for Orient EuroPharma Co., Ltd. (4120.TWO)?
What is the 3-year average ROE for Orient EuroPharma Co., Ltd. (4120.TWO)?
What is the 5-year average ROE for Orient EuroPharma Co., Ltd. (4120.TWO)?
How does the current ROE for Orient EuroPharma Co., Ltd. (4120.TWO) compare to its historical average?